LIVE MARKETS-Is Medtech ready to turn the corner?

Reuters01-22

LIVE MARKETS-Is Medtech ready to turn the corner?

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com

IS MEDTECH READY TO TURN THE CORNER?

After five straight years of underperformance, the medtech sector may finally be approaching an inflection point.

Italian broker Equita says the weak run of the iShares US Medical Devices ETF IHI.P – their proxy for medtech - has pushed valuations to their lowest relative levels in two decades, even as fundamentals look set to improve.

Sentiment has been battered by policy headwinds: U.S. healthcare budgets have come under pressure, Europe has refocused spending on rearmament and China has extended volumes‑based procurement to a wider set of devices.

That backdrop contributed to a modest 4% EPS CAGR for the sector between 2023 and 2025.

But Equita analyst Davide Marchesin expects earnings momentum to pick up, with EPS growth seen more than doubling to 10% this year and trebling to 12% in 2027.

Meanwhile, the ETF trades at only a 10% premium to the S&P 500 .SPX on a forward PE metric, well below the long-term 35% average premium.

Marchesin highlights three preferred picks for the quarter: Diasorin DIAS.MI, EssilorLuxottica ESLX.PA and Straumann STMN.S.

(Danilo Masoni)

*****

EARLIER ON LIVE MARKETS:

EUROPE HITCHES A RIDE ON THE TACO RALLY CLICK HERE

STOXX SET FOR TACO TUESDAY CLICK HERE

EUROPE BEFORE THE BELL: STOXX HEADS FOR GAINS CLICK HERE

Spot gold price in USD per oz https://reut.rs/4sSPH2s

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2605460723?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-22 19:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2605460723","market":"nz","top_or_hot":-1,"title":"LIVE MARKETS-Is Medtech ready to turn the corner?","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>LIVE MARKETS-Is Medtech ready to turn the corner?</title></head><body><p>Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com</p><p>IS MEDTECH READY TO TURN THE CORNER?</p><p>After five straight years of underperformance, the medtech sector may finally be approaching an inflection point. </p><p>Italian broker Equita says the weak run of the <a href=\"https://laohu8.com/S/EEMA\">iShares</a> US Medical Devices ETF <span>IHI.P</span> – their proxy for medtech - has pushed valuations to their lowest relative levels in two decades, even as fundamentals look set to improve.</p><p>Sentiment has been battered by policy headwinds: U.S. healthcare budgets have come under pressure, Europe has refocused spending on rearmament and China has extended volumes‑based procurement to a wider set of devices. </p><p>That backdrop contributed to a modest 4% EPS CAGR for the sector between 2023 and 2025.</p><p>But Equita analyst Davide Marchesin expects earnings momentum to pick up, with EPS growth seen more than doubling to 10% this year and trebling to 12% in 2027. </p><p>Meanwhile, the ETF trades at only a 10% premium to the S&amp;P 500 <span>.SPX</span> on a forward PE metric, well below the long-term 35% average premium.</p><p>Marchesin highlights three preferred picks for the quarter: Diasorin <span>DIAS.MI</span>, <a href=\"https://laohu8.com/S/ESLOF\">EssilorLuxottica</a> <span>ESLX.PA</span> and Straumann <span>STMN.S</span>.</p><p>(Danilo Masoni)</p><p>*****</p><p>EARLIER ON LIVE MARKETS:</p><p>EUROPE HITCHES A RIDE ON THE TACO RALLY <span>CLICK HERE</span></p><p>STOXX SET FOR TACO TUESDAY <span>CLICK HERE</span></p><p>EUROPE BEFORE THE BELL: STOXX HEADS FOR GAINS <span>CLICK HERE</span></p><div><p>Spot gold price in USD per oz https://reut.rs/4sSPH2s</p></div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LIVE MARKETS-Is Medtech ready to turn the corner?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLIVE MARKETS-Is Medtech ready to turn the corner?\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-01-22 19:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>LIVE MARKETS-Is Medtech ready to turn the corner?</title></head><body><p>Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com</p><p>IS MEDTECH READY TO TURN THE CORNER?</p><p>After five straight years of underperformance, the medtech sector may finally be approaching an inflection point. </p><p>Italian broker Equita says the weak run of the <a href=\"https://laohu8.com/S/EEMA\">iShares</a> US Medical Devices ETF <span>IHI.P</span> – their proxy for medtech - has pushed valuations to their lowest relative levels in two decades, even as fundamentals look set to improve.</p><p>Sentiment has been battered by policy headwinds: U.S. healthcare budgets have come under pressure, Europe has refocused spending on rearmament and China has extended volumes‑based procurement to a wider set of devices. </p><p>That backdrop contributed to a modest 4% EPS CAGR for the sector between 2023 and 2025.</p><p>But Equita analyst Davide Marchesin expects earnings momentum to pick up, with EPS growth seen more than doubling to 10% this year and trebling to 12% in 2027. </p><p>Meanwhile, the ETF trades at only a 10% premium to the S&amp;P 500 <span>.SPX</span> on a forward PE metric, well below the long-term 35% average premium.</p><p>Marchesin highlights three preferred picks for the quarter: Diasorin <span>DIAS.MI</span>, <a href=\"https://laohu8.com/S/ESLOF\">EssilorLuxottica</a> <span>ESLX.PA</span> and Straumann <span>STMN.S</span>.</p><p>(Danilo Masoni)</p><p>*****</p><p>EARLIER ON LIVE MARKETS:</p><p>EUROPE HITCHES A RIDE ON THE TACO RALLY <span>CLICK HERE</span></p><p>STOXX SET FOR TACO TUESDAY <span>CLICK HERE</span></p><p>EUROPE BEFORE THE BELL: STOXX HEADS FOR GAINS <span>CLICK HERE</span></p><div><p>Spot gold price in USD per oz https://reut.rs/4sSPH2s</p></div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nL8N3YN0TL:1","article_id":"2605460723","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2605460723","pubTimestamp":1769080499,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"LIVE MARKETS-Is Medtech ready to turn the corner?Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thom","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","IHI":"iShares Dow Jones U.S. Medical D","BK4588":"碎股"},"translate_title":"实时市场——医疗技术准备好转危为安了吗？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IHI":0.9},"content_text":"LIVE MARKETS-Is Medtech ready to turn the corner?Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.comIS MEDTECH READY TO TURN THE CORNER?After five straight years of underperformance, the medtech sector may finally be approaching an inflection point. Italian broker Equita says the weak run of the iShares US Medical Devices ETF IHI.P – their proxy for medtech - has pushed valuations to their lowest relative levels in two decades, even as fundamentals look set to improve.Sentiment has been battered by policy headwinds: U.S. healthcare budgets have come under pressure, Europe has refocused spending on rearmament and China has extended volumes‑based procurement to a wider set of devices. That backdrop contributed to a modest 4% EPS CAGR for the sector between 2023 and 2025.But Equita analyst Davide Marchesin expects earnings momentum to pick up, with EPS growth seen more than doubling to 10% this year and trebling to 12% in 2027. Meanwhile, the ETF trades at only a 10% premium to the S&P 500 .SPX on a forward PE metric, well below the long-term 35% average premium.Marchesin highlights three preferred picks for the quarter: Diasorin DIAS.MI, EssilorLuxottica ESLX.PA and Straumann STMN.S.(Danilo Masoni)*****EARLIER ON LIVE MARKETS:EUROPE HITCHES A RIDE ON THE TACO RALLY CLICK HERESTOXX SET FOR TACO TUESDAY CLICK HEREEUROPE BEFORE THE BELL: STOXX HEADS FOR GAINS CLICK HERESpot gold price in USD per oz https://reut.rs/4sSPH2s","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2605460723","isCrawlerRequest":true}